Back to Journals » ImmunoTargets and Therapy » Volume 6

Phase I clinical trial of sipuleucel-T combined with escalating doses of ipilimumab in progressive metastatic castrate-resistant prostate cancer

Total article views   HTML views PDF downloads Totals
10,384 Dovepress* 9,167+ 1,938 11,105
PubMed Central* 1,217 367 1,584
Totals 10,384 2,305 12,689
*Since 20 March 2017
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 2 2

View citations on PubMed Central and Google Scholar